Delaware News

Minkus Electronic Display Systems, Inc. and Remote Media Group today announced that Remote Media Group has entered into a license agreement with Minkus Electronic Display Systems for United States Patent Number 5,309,174. The license agreement resolves the dispute between the parties that was pending in the United States District Court for the District of Delaware. About Minkus Electronic Display Systems, Inc. Minkus Electronic Display Systems, Inc. is a premier licensor of digital display technology patented in United States Patent Number 5,309,174, ... read more

Today, Chase Card Services, a division of JPMorgan Chase & Co. [NYSE: JPM], announced it is the first major U.S. bank to issue chip-and-signature, a credit card with EVM chip technology that provides consumers with better ease-of-use and stronger security while traveling abroad. Chase will ... read more

iBio, Inc. (NYSE AMEX: IBIO) today announced release of results from a series of scientific studies of the breadth of product applicability of its iBioLaunch™ technology. The results were published in a supplemental edition of the scientific journal Human Vaccines. The peer-reviewed scientific manuscripts describe both ... read more

The Jefferson Awards for Public Service were awarded to five AstraZeneca (NYSE: AZN) employees Monday, recognizing significant contributions to their local communities through volunteerism. The Jefferson Awards is a national recognition program that honors individuals across the country who perform outstanding community and public service. ... read more

Are the risk mitigation measures within a REMS (Risk Evaluation and Mitigation Strategy) adequate enough to ensure optimal benefit-risk management? Even if the FDA doesn’t require a REMS for a product, does it make sense to undertake risk management measures anyway? ... read more

iBio, Inc. (NYSE AMEX:IBIO) today announced that Terence E. Ryan, Ph.D., iBio’s Senior Vice-President, will represent iBio in joint marketing presentations with representatives of GE Healthcare as part of the GE Healthcare Bioprocess Tour in Taipei, Shanghai and Beijing beginning today and extending through April 15. ... read more

The Delaware BioScience Association (Delaware Bio) will host its fourth Annual Awards Gala on April 11, 2011 at the DuPont Country Club. The event will honor five individuals who have made significant contributions to the state's life science community. Over 300 academic, government and industry leaders ... read more

All-Natural Dietary Supplement for Breast Enhancement Launched WILMINGTON, DE, April 7 /PRNewswire/ - To view this Social Media Release, please enter the following address in your web browser. http://smr.newswire.ca/en/adorim/naturally-enhance-your-life-and-lifestyle /NOTE TO PHOTO EDITORS: The photo accompanying this social media release is also available at http://photos.newswire.ca. Images are free to accredited members of the media/ SOURCE Secoah Pharmaceutical ... read more

Acorn Energy, Inc. (NASDAQ: ACFN) announced today that the company has sold its 25% interest in HangXing International Automation Engineering Co. Ltd. ("HangXing") back to the majority owner, China Aero-Polytechnology Establishment ("CAPE") for $492,000. HangXing is a value-added reseller for programmable logic controller (PLC) based industrial automation systems for steel manufacturing. For many years HangXing was supported by loans from CAPE. HangXing is no longer strategic to ACFN, and both owners were looking to rationalize the share structure. ... read more

Incyte Corporation (NASDAQ: INCY) announced today that it has earned a $15 million payment from Novartis based on the achievement of a predefined milestone in an ongoing Phase I dose- escalation trial for INCB28060 (also known as INC280) in patients with solid tumors. This trial is ... read more

Hosting.com, the leading provider of cloud hosting and recovery services, today announced its partnership with LinkTiger, a leading link validation solution. LinkTiger is a simple Software-as-a-Service (SaaS) solution that manages the validity of links on a customer's website to prevent broken links and lost revenue. LinkTiger provides marketing managers, Web masters, bloggers or anyone who owns or manages websites with a powerful tool to find broken links so that the links can be fixed before being noticed by their customers. LinkTiger ... read more

Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of SRA International, Inc. (“SRA” or the “Company”) (NYSE: SRX) concerning possible breaches of fiduciary duty and other violations of law related to the ... read more

Continuing budget constraints, lack of internal expertise coupled with diminishing support from Sungard Higher Education presents a huge challenge for community colleges and universities throughout the Higher Education Sector utilizing the Banner platform. ERP an Oracle gold partner announces an initiative to provide a complete set of implementation, conversion and migration services focused on Higher Education clients who utilize the Sungard Banner application suite. The foundation of the program is based on extensive Higher Education Sector knowledge combined with ... read more

Lightwave Logic, Inc. (OTC Bulletin Board: LWLG), a technology company focused on the development of a Next Generation Non Linear Optical Polymer Materials Platform for applications in high speed fiber-optic data communications and optical computing, announced today that the USPTO will issue US Patent No. 7,919,619 on April 5, 2011 for Heterocyclical Chromophore Architectures directed to Perkinamine(TM) chromophores, the foundation of Lightwave's unique electro-optic materials platform. Additionally, the company has been issued US Patent No. 7,894,695 covering its Tricyclic ... read more

Christiana Care Health System's Helen F. Graham Cancer Center is leading a national clinical trial to determine if Crestor® (Rosuvastatin), a cholesterol-lowering drug, can prevent new colon tumors from forming after colon cancer surgery. (Logo: http://photos.prnewswire.com/prnh/20090407/DC95299LOGO) The study seeks to determine if Crestor can stop the growth of tumor cells by blocking some of the enzymes that affect cell growth. The trial will also determine if Crestor can keep new colon tumors from forming after surgery to remove a patient's ... read more

Christiana Care Health System's Medical Director of Trauma and Neurocritical Care, Mark Cipolle, M.D., Ph.D., is the recipient of a $130,000 research grant from the National Trauma Institute to study platelet transfusion in patients with brain hemorrhage, the most common cause of death and disability after injury or stroke. (Logo: http://photos.prnewswire.com/prnh/20090407/DC95299LOGO) "Antiplatelet medications used to reduce the risk of heart attack and stroke in trauma patients likely worsens a hemorrhage once it has occurred," says Dr. Cipolle. "We are grateful to the ... read more

The National Association for Female Executives (NAFE) today named AstraZeneca (NYSE: AZN) as one of the top 50 companies for female executives for the third consecutive year. NAFE recognizes organizations for policies and practices that encourage ... read more

COMFORT-II, the second pivotal Phase III trial of Incyte Corporation’s (Nasdaq: INCY) investigational Janus kinase (JAK) inhibitor, ruxolitinib (INCB18424 or INC424), has met its primary endpoint of significantly reducing spleen size in patients with myelofibrosis (MF), when compared to best available therapy. This trial was conducted ... read more

Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of Lawson Software, Inc. (“Lawson Software” or the “Company”) (Nasdaq: LWSN) concerning the Company’s receipt of a proposal from Infor and Golden Gate Capital ... read more

AstraZeneca (NYSE: AZN) today announced the launch of a partnership with Food University(TM) -- a culinary education and entertainment platform -- to educate people about the importance of maintaining a healthy diet as one way to help manage cholesterol. In support of its cholesterol-lowering medication CRESTOR® (rosuvastatin calcium), the AstraZeneca partnership with Food University aims to empower people to take control of their health by showing how even small changes, like incorporating more low-cholesterol foods into their diet, can make ... read more